Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
UTHR
#564
United Therapeutics Corporation - Common Stock
527.9
1
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.17%
Monthly Change
+0.35%
6 month change
+3.60%
Year Change
+71.87%
Previous Close
516.6
8
Open
527.9
1
Low
527.9
1
High
527.9
1
Volume
98
Markets
US Stock Market
Healthcare
Biotechnology
UTHR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
1999
Annual report, Q4 FY1999
2000.03.22
UNITED THERAPEUTICS Corp annual report, Q4 FY1999
10-K
Quarterly report, Q3 FY1999
1999.11.15
UNITED THERAPEUTICS Corp quarterly report, Q3 FY1999
10-Q
Quarterly report, Q2 FY1999
1999.08.16
UNITED THERAPEUTICS Corp quarterly report, Q2 FY1999
10-Q
1
...
32
33
34
35
36
37
38
39
News
Will LQDA's Differentiated PAH Approach Drive Growth?
Tracking Renaissance Technologies (RenTec) 13F Portfolio – Q2 2026 Update
Can Merck's New Drugs Offer Growth Cushion Ahead of Keytruda LOE?
Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion?
UTHR Completes Phase III Tyvaso Study Enrollment for Expanded Label
LQDA Stock Down Post Q2 Earnings Release: What Should Investors Do Now?
LQDA Q2 Earnings Top, Strong Yutrepia Sales Fuel Top-Line Growth
Why No. 2 IBD 50 Stock, Liquidia, Dropped Despite Its Sales Beat
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark
United Therapeutics (UTHR) Reports Q2 Earnings: What Key Metrics Have to Say
United Therapeutics (UTHR) Q2 Earnings Surpass Estimates
UTHR or SDZNY: Which Is the Better Value Stock Right Now?